| Healthcare resource utilization and economic impact of a ≥2 g/dL decrease in hemoglobin in osteoarthritis patients. | |
| | |
MedLine Citation:
|
PMID: 23339465 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Abstract Objective: In nonsteroidal anti-inflammatory drug (NSAID) users, chronic occult blood loss may lead to decreases in hemoglobin, which may lead to increased healthcare expenditures. We therefore sought to quantify healthcare resource utilization of ≥2 g/dL hemoglobin decrease in osteoarthritis patients. Methods: Using a large US managed care database, we evaluated osteoarthritis patients aged ≥18 years who had exposure to ≥90 days of nonselective or selective COX-2 NSAID use, a hemoglobin value within 6 months before index NSAID and at least one hemoglobin value 24 months after. Resource utilization was evaluated in those with ≥2 g/dL hemoglobin drop versus patients with ≤0.5 g/dL hemoglobin drop (control). Results: Of 1800 NSAID users meeting inclusion criteria, 228 patients [mean (SD): 59.8 (9.3) years] had ≥2 g/dL hemoglobin drop versus 1572 controls [mean (SD) 58.3 (8.0) years]. Despite relatively low absolute rates, endoscopic procedures were more commonly observed in the ≥2 g/dL hemoglobin drop group [endoscopy: 37/228 (16.2%) vs. 65/1572 (4.1%); adjusted odds ratio (AOR) 3.5, (95% confidence interval [CI] 2.1-6.0); colonoscopy: 36/228 (15.8%) vs. 137/1572 (8.7%); AOR 2.0 (95% CI 1.2-3.2)]. During the 12-month follow-up, patients with ≥2 g/dL hemoglobin drop utilized significantly more healthcare resources [adjusted relative risk (95% CI) for hospitalization, 2.1 (1.5-2.9); outpatient visits, 1.4 (1.3-1.5); physician visits, 1.3 (1.1-1.4)] and charges (total adjusted charges $47,766 vs. $23,342) across major categories of healthcare services. Limitations: This was a retrospective analysis with baseline demographic differences. The source or cause of the hemoglobin drops could not be verified; and it is assumed that they are related to occult gastrointestinal loss. Differences with healthcare utilization and charges were not linked to hemoglobin-associated complications. Conclusion: In patients exposed to NSAIDs, those with significant hemoglobin drops experienced higher subsequent healthcare utilization and charges than controls who did not have a significant hemoglobin drop. |
| | |
Authors:
|
Jay L Goldstein; Xuemei Luo; Joseph C Cappelleri; George H Sands |
Related Documents
:
|
7503575 - Photosensitivity associated with combined uv-b and calcipotriene therapy. 3149925 - Comparison of etretinate (tigason) and parenteral gold in the treatment of psoriatic ar... 16019625 - Audit of the use of psoralen photochemotherapy (puva) and narrowband uvb phototherapy i... 19289755 - Evaluation of the efficacy of acitretin therapy for nail psoriasis. 17068705 - No difference in health-related quality of life in hip osteoarthritis compared to degen... 17383335 - Practical regimen for amiodarone use in preventing postoperative atrial fibrillation. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-1-22 |
Journal Detail:
|
Title: Journal of medical economics Volume: - ISSN: 1941-837X ISO Abbreviation: J Med Econ Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-1-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9892255 Medline TA: J Med Econ Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prasugrel vs. Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary ...
Next Document: Chromium(IV) Siloxide.